Laura J. Buyan Dent
MD, PhD

  • Neurology

About

Dr. Buyan Dent is a neurologist in the Movement Disorders Program. Dr. Buyan Dent's main focus is the care of patients with Parkinson's disease, Huntington's disease, essential tremor, dystonia, multiple systems atrophy, progressive supranuclear palsy and other movement disorders. With state-of-the-art pharmaceutical treatments, botulinum toxin injections and surgical management options, Dr. Buyan Dent helps patients with a unique program that suits their particular conditions.

As part of the Performing Arts Medicine Program, she is dedicated to the care of artists with neurologic conditions such as tremors, dystonias and ataxias, that may interfere with performance and movement. She also helps with performance-related overuse conditions or injuries that result in focal dystonia, nerve injuries, weakness, tremors and coordination difficulties.

Languages spoken
  • English
University affiliation
  • Department of Neurology

Practice locations

Loading...
  • University Hospital - Movement Disorders Clinic (Neurology)
    • 600 Highland Ave. / Madison, WI
    • (608) 263-5442
    • Closed now
    •  
      View hours, services and more

Education & credentials

Board certifications
  • Neurology
Medical School
  • University of Wisconsin School of Medicine and Public Health (formerly UW Medical School), Madison, WI
Fellowships
  • Boston Medical Center, Boston, MA
Residencies
  • University of Wisconsin Hospital and Clinics, Madison, WI
Internships
  • University of Wisconsin Hospital and Clinics, Madison, WI

Specialties

  • Huntington's Disease
  • Tardive Dyskinesia
  • Torticollis
  • Tourette Syndrome
  • Myoclonus
  • Chorea
  • Dystonia
  • Gait Disorder
  • Restless Leg Syndrome
  • Tremors
  • Wilson's Disease
  • Movement Disorders
  • Deep Brain Stimulation Management
  • Botulinum Toxin Muscle Injection
  • Performing Arts Medicine - Neurological Conditions and Movement Disorders

Research and publications

Dr. Buyan Dent's previous research examined the rehabilitation of patients with atypical parkinsonian disorders. She hopes to implement clinical research trials to expand treatment options and knowledge in both Parkinson's and Huntington's Disease.